Awareness of Prediabetes Among Physicians

June 10, 2026 updated by: Hany Ahmed Mohamed, Sohag University

Prediabetes is associated with impaired fasting glucose and/or impaired glucose tolerance. Recent data indicate that more than one-third of adults in affluent countries have prediabetes . Fasting glucose concentrations of 100-125 mg/dL, hemoglobin A1c (HbA1c) titers of 5.7-6.4%, and two-hour post-stimulus glucose levels of 140-199 mg/dL are used to identify prediabetes. Behavioral lifestyle changes and medications are useful in preventing the progression of prediabetes to T2DM .

Early detection and treatment of T2DM and prediabetes can prevent future health problems. However, many people with metabolic disorders are undiagnosed, partly due to the clinical practices and knowledge of primary care physicians (PCPs). PCPs play a critical role in diabetes prevention through the detection and management of prediabetes. Successful screening initiatives and the start of appropriate management interventions depend on PCPs' level of prediabetes knowledge Most patients with prediabetes do not receive evidence-based preventive care from their PCPs . Systemic barriers hinder physicians' ability to provide the best evidence-based practice, such as performance measures, insurance reimbursement, cultural expectations, and a lack of tools and staffing resources

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Sohag, Egypt
        • Sohag University Faculty of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

physicians (faculty medical staff) at Sohag government hospitals and clinics, Egypt (target n=500, all specialties and training levels).

Description

Inclusion Criteria:

  1. - Physicians working at Sohag government hospitals and clinics
  2. Faculty medical staff (any specialty)
  3. Willing to complete the self-administered questionnaire
  4. Provide informed written consent to participate in the study

Exclusion Criteria:

1 - Physicians who decline to provide informed consent.

2-Physicians who do not complete at least 90% of the questionnaire items.

3-Physicians not actively practicing at a Sohag government hospital or clinic during the study period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physician awareness of prediabetes risk factors, diagnostic criteria, and management recommendations
Time Frame: Single time point during data collection period (April 1, 2026 to June 30, 2026)
Proportion of physicians who correctly identify: (1) risk factors for diabetes screening (e.g., age ≥35, BMI ≥25 kg/m², hypertension, family history of diabetes), (2) fasting glucose diagnostic cut-offs for prediabetes (100-125 mg/dL) and diabetes (≥126 mg/dL), (3) HbA1c cut-offs for prediabetes (5.7-6.4%) and diabetes (≥6.5%), (4) lifestyle modification recommendations for prediabetes (minimum 7% weight loss and 150 minutes of physical activity per week), and (5) appropriate use of metformin for prediabetes prevention.Validated structured self-administered questionnaire (adapted from Tseng et al., 2019) distributed via Google Forms, including multiple-choice and true/false questions
Single time point during data collection period (April 1, 2026 to June 30, 2026)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

June 10, 2026

First Submitted That Met QC Criteria

June 10, 2026

First Posted (Actual)

June 16, 2026

Study Record Updates

Last Update Posted (Actual)

June 16, 2026

Last Update Submitted That Met QC Criteria

June 10, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-Med-26-5--10PD

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pre Diabetes

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe